A Best Practice Guide to CDISC SDTM Mapping

Stay ahead with the ultimate best practice resource for mapping to SDTM

If you’re involved in SDTM mapping, don’t miss this chance to master the essentials with our comprehensive guide.

Why this guide is a must-have:

💡 A key learning step in your planning + implementation process

⚠️ Explains how to avoid typical mapping issues

💪 Equips you with a 4-step best practice approach to mapping

The top 3 weaknesses when it comes to SDTM mapping are:

Lack of key knowledge around the mapping specification document
Taking a retrospective approach to CDISC SDTM mapping
Poor understanding of how to handle common mapping scenarios

This resource addresses these learning gaps and equips you with best practice guidance for tackling mappings. Simply complete the form to download your guide.

What you’ll learn in this guide:

A breakdown of the SDTM mapping process

How the mapping specification document helps identify problems upfront

The 9 typical mapping scenarios you’re likely to encounter

Why it’s important to consider SDTM before data collection

Best practice checklist

About the authors

Ed Chappell

Solutions Consultant

Ed Chappell, Solutions Consultant with over 15 years’ tenure, is a recognized expert in clinical data programming and SDTM dataset mapping. He has been instrumental in developing the dataset mapper, delivering advanced training on SEND and SDTM standards, and supporting customers with FDA submissions and Interim Analysis SDTM needs.

Download the guide

Submit the form below to download your guide and make CDISC SDTM mapping a little easier!

About Certara

Certara is dedicated to transforming drug discovery and development for good. We harness the power of biosimulation, advanced analytics, and regulatory expertise to create a future where treatments reach patients faster and more efficiently.

From discovery to market access and commercial, we tailor solutions to meet our clients’ most pressing challenges. Through strategic leadership and advanced predictive technologies, Certara provides comprehensive solutions to optimize drug development processes, reduce risks, and improve outcomes. Our clients include more than 2,400 biopharmaceutical companies, academic institutions, and regulatory agencies across 70 countries.